Evidence map›Paper›PMID 38972927›Full record

ReviewAnnals of surgical oncology2024

Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review.

Elliott J Yee, Ioannis A Ziogas, Dimitrios P Moris, Robert J Torphy, Benedetto Mungo, Ana L Gleisner, Marco Del Chiaro, Richard D Schulick

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elliott J YeeDivision of Surgical Oncology, Department of Surgery, University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Ioannis A ZiogasDivision of Surgical Oncology, Department of Surgery, University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Dimitrios P MorisDepartment of Surgery, Duke University Medical Center, Durham, NC, USA.
Robert J TorphyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Benedetto MungoDivision of Surgical Oncology, Department of Surgery, University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Ana L GleisnerDivision of Surgical Oncology, Department of Surgery, University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Marco Del ChiaroDivision of Surgical Oncology, Department of Surgery, University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Richard D SchulickDivision of Surgical Oncology, Department of Surgery, University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Richard.schulick@cuanschutz.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resectable cholangiocarcinoma (CCA) arising from the middle of the extrahepatic biliary tree has historically been classified as perihilar or distal CCA, depending on the operation contemplated or performed, namely the associated hepatectomy or pancreaticoduodenectomy, respectively. Segmental bile duct resection is a less invasive alternative for select patients harboring true middle extrahepatic CCA (MCC). A small, yet growing body of literature has emerged detailing institutional experiences with bile duct resection versus pancreaticoduodenectomy or concomitant hepatectomy for MCC. Herein, we provide a brief overview of the epidemiology, preoperative evaluation, and emerging systemic therapies for MCC, and narratively review the existing work comparing segmental resection with pancreaticoduodenectomy or less commonly, hepatectomy, for MCC, with emphasis on the surgical management and oncologic implications of the approach used.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaHepatectomyHumansPancreaticoduodenectomyCholangiocarcinomaHepatectomyPancreaticoduodenectomySegmental bile duct resection

Identifiers

PMID38972927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.